Geode Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.2M | Buy |
|
|||||
|
2025
Q1 | $24.9M | Buy |
|
|||||
|
2024
Q4 | $26.1M | Sell |
|
|||||
|
2024
Q3 | $38.1M | Buy |
|
|||||
|
2024
Q2 | $39.2M | Buy |
|
|||||
|
2024
Q1 | $42.3M | Buy |
|
|||||
|
2023
Q4 | $33.2M | Buy |
|
|||||
|
2023
Q3 | $19.8M | Buy |
|
|||||
|
2023
Q2 | $27.7M | Buy |
|
|||||
|
2023
Q1 | $25.9M | Buy |
|
|||||
|
2022
Q4 | $28M | Buy |
|
|||||
|
2022
Q3 | $23.3M | Buy |
|
|||||
|
2022
Q2 | $17.5M | Buy |
|
|||||
|
2022
Q1 | $14.9M | Buy |
|
|||||
|
2021
Q4 | $16.7M | Buy |
|
|||||
|
2021
Q3 | $14M | Buy |
|
|||||
|
2021
Q2 | $12.1M | Buy |
|
|||||
|
2021
Q1 | $12.7M | Buy |
|
|||||
|
2020
Q4 | $10.3M | Buy |
|
|||||
|
2020
Q3 | $6.08M | Sell |
|
|||||
|
2020
Q2 | $6.14M | Buy |
|
|||||
|
2020
Q1 | $3.65M | Buy |
|
|||||
|
2019
Q4 | $2.63M | Buy |
|
|||||
|
2019
Q3 | $2.14M | Buy |
|
|||||
|
2019
Q2 | $2.5M | Buy |
|
|||||
|
2019
Q1 | $1.04M | Buy |
|
|||||
|
2018
Q4 | $801K | Buy |
|
|||||
|
2018
Q3 | $1.4M | Buy |
|
|||||
|
2018
Q2 | $1.18M | Buy |
|
|||||
|
2018
Q1 | $2.2M | Buy |
|
|||||
|
2017
Q4 | $1.34M | Buy |
|
|||||
|
2017
Q3 | $1.53M | Buy |
|
|||||
|
2017
Q2 | $1.76M | Buy |
|
|||||
|
2017
Q1 | $1.36M | Buy |
|
|||||
|
2016
Q4 | $642K | Buy |
|
|||||
|
2016
Q3 | $1.32M | Buy |
|
|||||
|
2016
Q2 | $295K | Buy |
|